rs2229110
Variant names: 
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000815.5(GABRD):c.330T>C(p.Gly110Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.633 in 1,612,716 control chromosomes in the GnomAD database, including 327,885 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.65   (  33159   hom.,  cov: 34) 
 Exomes 𝑓:  0.63   (  294726   hom.  ) 
Consequence
 GABRD
NM_000815.5 synonymous
NM_000815.5 synonymous
Scores
 7
Clinical Significance
Conservation
 PhyloP100:  -1.22  
Publications
21 publications found 
Genes affected
 GABRD  (HGNC:4084):  (gamma-aminobutyric acid type A receptor subunit delta) Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. The GABA-A receptor is generally pentameric and there are five types of subunits: alpha, beta, gamma, delta, and rho. This gene encodes the delta subunit. Mutations in this gene have been associated with susceptibility to generalized epilepsy with febrile seizures, type 5. Alternatively spliced transcript variants have been described for this gene, but their biological validity has not been determined. [provided by RefSeq, Jul 2008] 
GABRD Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics, ClinGen
 - epilepsyInheritance: AD Classification: LIMITED Submitted by: ClinGen
 - epilepsy, idiopathic generalized, susceptibility to, 10Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=9.98378E-7). 
BP6
Variant 1-2025598-T-C is Benign according to our data. Variant chr1-2025598-T-C is described in ClinVar as Benign. ClinVar VariationId is 256823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-1.22 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.721  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GABRD | NM_000815.5  | c.330T>C | p.Gly110Gly | synonymous_variant | Exon 4 of 9 | ENST00000378585.7 | NP_000806.2 | |
| GABRD | XM_017000936.2  | c.1035T>C | p.Gly345Gly | synonymous_variant | Exon 3 of 8 | XP_016856425.1 | ||
| GABRD | XM_011541194.4  | c.369T>C | p.Gly123Gly | synonymous_variant | Exon 4 of 9 | XP_011539496.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.655  AC: 99494AN: 151996Hom.:  33171  Cov.: 34 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
99494
AN: 
151996
Hom.: 
Cov.: 
34
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.588  AC: 147340AN: 250576 AF XY:  0.589   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
147340
AN: 
250576
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.630  AC: 920909AN: 1460604Hom.:  294726  Cov.: 57 AF XY:  0.627  AC XY: 455681AN XY: 726602 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
920909
AN: 
1460604
Hom.: 
Cov.: 
57
 AF XY: 
AC XY: 
455681
AN XY: 
726602
show subpopulations 
African (AFR) 
 AF: 
AC: 
24481
AN: 
33476
American (AMR) 
 AF: 
AC: 
21773
AN: 
44716
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
18198
AN: 
26132
East Asian (EAS) 
 AF: 
AC: 
14303
AN: 
39696
South Asian (SAS) 
 AF: 
AC: 
40907
AN: 
86256
European-Finnish (FIN) 
 AF: 
AC: 
33484
AN: 
52304
Middle Eastern (MID) 
 AF: 
AC: 
4084
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
725697
AN: 
1111880
Other (OTH) 
 AF: 
AC: 
37982
AN: 
60376
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.489 
Heterozygous variant carriers
 0 
 20647 
 41294 
 61942 
 82589 
 103236 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 18814 
 37628 
 56442 
 75256 
 94070 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.654  AC: 99507AN: 152112Hom.:  33159  Cov.: 34 AF XY:  0.647  AC XY: 48096AN XY: 74338 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
99507
AN: 
152112
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
48096
AN XY: 
74338
show subpopulations 
African (AFR) 
 AF: 
AC: 
30232
AN: 
41514
American (AMR) 
 AF: 
AC: 
9158
AN: 
15288
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2469
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
1757
AN: 
5160
South Asian (SAS) 
 AF: 
AC: 
2235
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
6780
AN: 
10584
Middle Eastern (MID) 
 AF: 
AC: 
215
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
44549
AN: 
67960
Other (OTH) 
 AF: 
AC: 
1390
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.509 
Heterozygous variant carriers
 0 
 1812 
 3624 
 5435 
 7247 
 9059 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 786 
 1572 
 2358 
 3144 
 3930 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
TwinsUK 
 AF: 
AC: 
2477
ALSPAC 
 AF: 
AC: 
2516
ESP6500AA 
 AF: 
AC: 
3220
ESP6500EA 
 AF: 
AC: 
5680
ExAC 
 AF: 
AC: 
71860
Asia WGS 
 AF: 
AC: 
1444
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:5 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 06, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Epilepsy, idiopathic generalized, susceptibility to, 10    Benign:1 
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Idiopathic generalized epilepsy    Benign:1 
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 FATHMM_MKL 
 Benign 
N 
 LIST_S2 
 Benign 
T 
 MetaRNN 
 Benign 
T 
 PhyloP100 
 GERP RS 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.